News & Views

Adobestock 602058904

First patient dosed in Phase 1 Trial

Iksuda announces first patient dosed in Phase 1 trial of IKS014

Sign up for more news

Thank you
*required field
*required field
*required field
I confirm that I have read the data protection and Privacy Policy and that I agree to the processing of my personal data